The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Related Posts
Shimoda TM, Ueyama HA, Miyamoto Y, Watanabe A, Gotanda H, Elmariah S, Yokoyama Y, Fukuhara S, Kaneko T, Kuno T, Tsugawa Y. Outcomes of isolated[...]
Santos P, Rezende CP, Piraine R, Oliveira B, Ferreira FB, Carvalho VS, Calado RT, Pellegrini M, Almeida F. Corrigendum: Extracellular vesicles from human breast cancer-resistant[...]
Dancu CA, Schexnayder J, Bosworth HB, Lewinski A, Shapiro A, Lanford T, Clark CW, Bean-Mayberry B, Zullig LL, Gierisch JM, Goldstein KM. Tailoring Chronic Disease[...]